-
Buyout
Biofarma
Italy
Healthcare & life scienceHealthcare & life scienceBiofarma Group is the leader in Italy and Europe in the development, manufacturing, and packaging of food supplements, medical devices, probiotic-based products, and cosmetics. The Group is the result of a path of aggregation of 6 complementary nutraceuticals companies (Nutrilinea, Pharcoterm, Apharm, Claire, Biofarma, and the ‘Health Science’ division of Giellepi). As of today, the Group has revenue in excess of €230m and more than 800 employees.
Biofarma offers its clients an integrated offer, from research and development, to manufacturing and packaging of finished dosage form products, including regulatory support. The Group is recognized as the innovative leader in its market, offering its customers a broad portfolio of technologies and proprietary formulations by anticipating market trends.
The company has 4 manufacturing facilities in Mereto di Tomba (UD) (Headquarter), Gallarate (VA), San Pietro Viminario (PD), and Cusano Milanino (MI), and has 3 research and development centers which employ more than 50 R&D specialists. -
Buyout
Florida Food Products
USA
Food and IngredientsFood and IngredientsFounded in 1954 and based in Eustis, Florida, FFP operates a multifunctional production facility and is involved in manufacturing of food protection ingredients, vegetable juice concentrates and derivatives used in a multitude of food applications from savory to beverages, sports nutrition and meats, and are marketed globally. The Company has offered a portfolio of healthy, natural, clean label solutions for over 60 years. For additional information, please visit Florida Food Products’ website.
-
Buyout
Jakala
Italy
Business servicesBusiness servicesJakala is an Italian leader and among top firms in Europe engaged in the provision of performance-driven sales and marketing services, addressing a wide range of solutions covering the whole spectrum of Chief Marketing Officers’ needs. Jakala’s solutions offered to clients’ sales and marketing departments include loyalty and engagement services (end-to-end management including tech platforms and rewards) for all sectors, as well as Data and Analytics, CRM Implementation, Geo Intelligence (location analytics), Advisory, Digital Media and other tech-enabled services. As of today, Jakala Group, with more than 1,000 employees, has revenue of around €300 million, c.35% of which are generated internationally in c.16 countries.
-
Buyout
GBA Group
Germany
Healthcare & life scienceHealthcare & life scienceGBA Group is a leading independent provider of highest-quality bio-analytical laboratory services for food, environment, and pharmaceutical testing. The group focuses on tailor-made solutions to meet its clients’ needs, backed by its strong scientific expertise, very comprehensive service portfolio as well as continuous dialogue with its customers. Headquartered in Hamburg, GBA employs well over 1,000 employees and operates more than 40 labs across central Europe.
-
Buyout
AD Education
France
EducationEducationFounded in 2009, AD Education is a leading European higher education platform, pure player in the field of Creative Arts, teaching to more than 18,000 students in 14 schools on 44 campuses in France, Italy, Spain and Germany. AD Education covers 4 main sub-segments: Design & Graphical Arts, Media & Digital, Audiovisual and Culture & Luxury. Over the past 10 years, the Group has established itself as the French leader on its core educational fields, following continued organic growth as well as successful build-ups, and as a sizeable European platform following acquisitions in Italy, Spain and Germany.
Deal team
Press releases
- Ardian-backed AD Education acquires Oktogone Group, a leading player in online education and training
- Ardian backed AD Education acquires the European operations of SAE Institute, a leader in Audiovisual and creative media higher education
- Ardian acquires a majority stake in AD Education, a European education platform specialized in arts, digital and audiovisual alongside its founder and CEO
-
Buyout
Inovie
France
Healthcare & life scienceHealthcare & life scienceFounded in 2010, Inovie has undergone significant external growth to become the leading independent medical diagnostic provider in France and a key player across Southern and Central France specifically. With a strong local footprint of 19 multi-site laboratories spread over five key regions (Occitanie, Provence-Alpes-Côte-d’Azur, Nouvelle Aquitaine Auvergne Rhône Alpes and Centre Val de Loire), Inovie’s biologists and 4,500 employees deliver high-standard clinical pathology testing to more than 50,000 patients daily. Inovie has also played a leading role in innovation, notably through their work in four areas of specialty: fertility (Inovie Fertilité), genomics (Imagenome), anatomopathology (Inopath) and veterinary services (Inovie Vet).